What does this research mean for the field?

The rs503464 genotype does not influence smoking cessation success. Novelty: ClaimNovelty.CONTRADICTORY. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

The research aims to evaluate the significance of CHRNA5 polymorphism genotype in smoking cessation outcomes.

March 13, 2026Open Access

The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy

Puntos clave

The research aims to evaluate the significance of CHRNA5 polymorphism genotype in smoking cessation outcomes.
Analyzed the rs503464 genotype in relation to smoking cessation success.
Examined the impact of genetic information on treatment personalization.
The rs503464 genotype did not affect smoking cessation rates.
Genetic information holds potential for informing anti-smoking therapies.

Resumen

Communication of the rs503464 genotype did not influence smoking cessation success, proving that it does not disturb this process. This result opens the possibility of using genetic information to personalize anti-smoking treatment.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Colombo et al. (Tue,) studied this question.

synapsesocial.com/papers/69b3ac3f02a1e69014ccdbd9 https://doi.org/https://doi.org/10.1177/03008916251408279

Me gusta

Guardar

Ver artículo completo